NEW YORK (GenomeWeb News) – CombiMatrix announced today that it will issue securities to certain accredited investors in a private placement that is expected to bring in proceeds of $2.4 million.

CombiMatrix said that it will sell Series C convertible preferred stock in two tranches. It expects the first tranche to close within the next two days and the second tranche to close following stockholder approval.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

 Senator Lamar Alexander (R-Tenn.), who chairs the Senate health committee, will be retiring at the end of his term, Stat News reports.

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

The Wall Street Journal reports on the US Centers for Disease Control and Prevention's use of genetic approaches to study foodborne illnesses.

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.